Looks like this may be a bit more relevant than many of the snarky comments would suggest - the relevant German authority on this said that they have seen a unexpected increase in a specific type of blood clotting issue that usually is very rare: https://www.pei.de/DE/newsroom/hp-meldungen/2021/210315-voru...
It's not a medically reasonable response that solicits snarky remarks, it's the complete retardation of the official covid response so far, and even reasonable decisions just are landing on a pile of steaming crap now. - billions per week of half assed lockdown vs a few billion more for high quality timeley vaccine delivieries of the good stuff --- of course they chose the lockdown - open schools as if nothing happen…
This is not the issue. A few billion would not have magically solved the problems with vaccine deliveries. The EU has contracts with pharmaceutical companies which these companies are not honoring sometimes intentionally so.
AstraZeneca for example doesn't have the production capacity to supply what they promised to the EU even if the Belgian site was working properly. That's the result of the EU audit. These companies are betting that the consequence of them not fullfiling their contractual obligation will be insignificant compared to their benefits. As these companies remain hugely profitable, their production issue is not linked to difficulty accessing capital. It is naive to assume things would have gone differently if the EU was paying more. It would just have meant more profits for them.
The heart of the issue is that contraty to the USA or China the EU is weak so companies don't hesitate trampling it. If a Chinese company did to China what AstraZeneca is doing to the EU, the CCP would take control of it and its CEO would never be seen again. Meanwhile, the USA has little qualm using its legal system to punish companies defying the state to much. Congressional inquiries are not fun.